Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinum-based chemotherapy (PCh) plus bev

K. Fujiwara,P. Harter, A. Leary, D. Perol,S. Pignata, A. González-Martín, E. Petru,E. van Nieuwenhuysen,N. Colombo,J. Mäenpää, F. Selle,N. de Gregorio, D. Lorusso,E.M. Guerra Alia, C. Lefeuvre-Plesse,P. Buderath,A. Lortholary, A. Burges,E. Pujade-Lauraine,I.L. Ray-Coquard

Annals of Oncology(2019)

引用 31|浏览101
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要